Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 235-240 , September 2006

A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement

  • Mariko Sassa

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Kazuhito Fukuda

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Shimpei Fujimoto

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Kentaro Toyoda

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Yoshihito Fujita

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Shinichi Matsumoto

      Affiliations

    • Kyoto University Hospital Transplantation Unit, Kyoto, Japan
    • ,
  • Teru Okitsu

      Affiliations

    • Department of Transplantation and Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Yasuhiro Iwanaga

      Affiliations

    • Department of Transplantation and Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Hirofumi Noguchi

      Affiliations

    • Department of Transplantation and Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Hideo Nagata

      Affiliations

    • Department of Transplantation and Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Yukihide Yonekawa

      Affiliations

    • Department of Transplantation and Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Takeshi Ohara

      Affiliations

    • Division of Diabetes, Digestive and Kidney Diseases, Kobe University Graduate School of Medicine, Japan
    • ,
  • Masahiko Okamoto

      Affiliations

    • Department of Organ interaction Research Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan
    • ,
  • Koichi Tanaka

      Affiliations

    • Kyoto University Hospital Transplantation Unit, Kyoto, Japan
    • Department of Transplantation and Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
    • ,
  • Yutaka Seino

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • Kansai-Denryoku Hospital, Osaka, Japan
    • ,
  • Nobuya Inagaki

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • ,
  • Yuichiro Yamada

      Affiliations

    • Department of Diabetes and Clinical Nutrition, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 75 751 3561; fax: +81 75 751 3677.

Received 15 September 2005 ,Revised 6 December 2005 ,Accepted 27 January 2006.

References 

  1. Schlichtkrull J, Munck O, Jersild M. The M-value, an index of blood-sugar control in diabetics. Acta Med. Scand. 1965;177:95–102
  2. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF, et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes. 1970;19:644–655
  3. Service FJ, Nelson RL. Characteristics of glycemic stability. Diabetes Care. 1980;3(1):58–62
  4. The Diabetes Control and Complications Trial (DCCT) Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch. Ophthalmol. 1998;116:874–876
  5. Allen KV, Frier BM. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr. Pract. 2003;9(6):530–543
  6. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 2000;343:230–238
  7. Ryan EA, Lakey JRT, Paty BW, Imes S, Korbutt GS, Kneteman NM, et al. Successful islet transplantation Continued insulin reserve provides long-term glycemic control. Diabetes. 2002;51:2148–2157
  8. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA. 2005;293:830–835
  9. Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, et al. Insulin independence after living-donor pancreatectomy and islet allotransplantation. Lancet. 2005;365(9741):1642–1644
  10. S. Matsumoto, T. Okitsu, Y. Iwanaga, H. Noguchi, H. Nagata, Y. Yonekawa, et al., Successful islet transplantation from non-heart-beating donor pancreata using modified Ricordi islet isolation method, Transplantation, in press.
  11. Rohlfing CL, Wiedmeyer H-M, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA1c. Diabetes Care. 2002;25:275–278
  12. Tominaga M, Kobayashi I, Kuwa K, Takei I, Hoshino T, Yoshino G, et al. HbA1c Value of JDS Lot 2 Determined by NSGP. J. Jpn. Diab. Soc. 2002;45(5):385–388
  13. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993;329:977–986
  14. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diab. Res. Clin. Pract. 1995;28:103–117
  15. Shapiro AMJ, Lakey JRT, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplantation. 2005;79:1304–1307
  16. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care. 1999;22:99–111
  17. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 2000;342:381–389
  18. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563–2569
  19. The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. JAMA. 2003;290:2159–2167
  20. The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 2003;348:2294–2303
  21. Riddle MC, Rosenstock J, Gerich J. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080–3086
  22. Rosenstock J. Basal insulin supplementation in type 2 diabetes: refining the tactics. Am. J. Med. 2004;116(3A):10S–16S
  23. Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005;28:950–955
  24. Radu RG, Fujimoto S, Mukai E, Takehiro M, Shimono D, Nabe K, et al. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity. Am. J. Physiol. 2005;288:E365–E371
  25. Bell E, Cao X, Moibi JA, Greene SR, Young R, Trucco M, et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes. 2003;52:2731–2739
  26. Paty BW, Harmon JS, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wister rat islets. Transplantation. 2002;73(3):353–357

PII: S0168-8227(06)00037-4

doi: 10.1016/j.diabres.2006.01.012

Diabetes Research and Clinical Practice
Volume 73, Issue 3 , Pages 235-240 , September 2006

Article Tools

* Image Usage & Resolution